Apis Assay Technologies LTD.

The DEVOTE programme is helping to bring cutting-edge genetic testing into everyday healthcare in Greater Manchester. By combining expertise from universities, hospitals, and businesses, it has already started improving patient care by making genetic testing a routine part of diagnosis and treatment. The next phase of DEVOTE will continue working with ind...

Across the developed world populations are rapidly aging leading to increasing prevalence of cancer, chronic disease, and dementia. Novel and more effective therapies are required for healthy aging. APIS recently acquired Clickmer technology and now has ambitious plans to develop Clickmers as innovative new drugs to tackle major health challenges includin...

A biomarker is a chemical or signal which can be measured from the human body to help to diagnose disease or predict future health states. Biomarkers are commonly used in healthcare to guide patient management, but there is a major translational bottleneck between the discovery of a clinically relevant biomarker and its implementation in routine practice ...

As part of the COVID-19 pandemic response, measuring the presence of an immune response to SARS-CoV-2 will be widely used to determine whether individuals have acquired immunity. Antibodies bind to specific sites on viral proteins. Measuring the presence of antibodies that can bind SARS-CoV-2 proteins in the plasma and serum can provide information about ...